检索结果 - Arkenau, Hendrik‐Tobias

Refine Results
  1. 1
    Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities

    Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities 由 Lemech, Charlotte, Arkenau, Hendrik-Tobias

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice

    Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice 由 Lemech, Charlotte, Arkenau, Hendrik-Tobias

    出版 2011
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence

    Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence 由 Voskoboynik, Mark, Arkenau, Hendrik-Tobias

    出版 2014
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Rationally designed treatment for metastatic colorectal cancer: Current drug development strategies

    Rationally designed treatment for metastatic colorectal cancer: Current drug development strategies 由 Spiliopoulou, Pavlina, Arkenau, Hendrik-Tobias

    出版 2014
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

    Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities 由 Fontana, Elisa, Arkenau, Hendrik-Tobias

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence

    The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence 由 Lemech, Charlotte, Infante, Jeffrey, Arkenau, Hendrik-Tobias

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    Advanced gastric cancer: Is there enough evidence to call second-line therapy standard?

    Advanced gastric cancer: Is there enough evidence to call second-line therapy standard? 由 Arkenau, Hendrik-Tobias, Saggese, Matilde, Lemech, Charlotte

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  8. 8
    Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

    Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment 由 Mak, Gabriel, Arkenau, Hendrik-Tobias, Chin, Melvin

    出版 2014
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  9. 9
    Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies

    Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies 由 Shih, Kent, Arkenau, Hendrik-Tobias, Infante, Jeffrey R.

    出版 2014
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  10. 10
    Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma

    Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma 由 Fostea, Raluca Maria, Fontana, Elisa, Torga, Gonzalo, Arkenau, Hendrik-Tobias

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  11. 11
    Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations

    Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations 由 Saggese, Matilde, Dua, Divyanshu, Simmons, Emily, Lemech, Charlotte, Arkenau, Hendrik-Tobias

    出版 2013
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  12. 12
    Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer

    Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer 由 Moschetta, Michele, Mak, Gabriel, Hauser, Joana, Davies, Catriona, Uccello, Mario, Arkenau, Hendrik-Tobias

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  13. 13
    Signal pathways and precision therapy of small-cell lung cancer

    Signal pathways and precision therapy of small-cell lung cancer 由 Yuan, Min, Zhao, Yu, Arkenau, Hendrik-Tobias, Lao, Tongnei, Chu, Li, Xu, Qing

    出版 2022
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  14. 14
    KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis

    KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis 由 Formica, Vincenzo, Sera, Francesco, Cremolini, Chiara, Riondino, Silvia, Morelli, Cristina, Arkenau, Hendrik-Tobias, Roselli, Mario

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  15. 15
    Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey

    Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey 由 Brunetto, Andre, Olmos, David, Arkenau, Hendrik-Tobias, Tan, Daniel, Yap, Timomy, de Bono, Johann, Barriuso, Jorge, Kaye, Stan

    出版 2011
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  16. 16
    Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

    Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade 由 Moschetta, Michele, Uccello, Mario, Kasenda, Benjamin, Mak, Gabriel, McClelland, Anissa, Boussios, Stergios, Forster, Martin, Arkenau, Hendrik-Tobias

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  17. 17
    Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

    Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT 由 Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer

    出版 2016
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  18. 18
    Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

    Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT 由 Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer

    出版 2016
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  19. 19
    Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

    Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer 由 Laille, Eric, Patel, Manish, Jones, Suzanne F., Burris, Howard A., Infante, Jeffrey, Lemech, Charlotte, Liu, Liangang, Arkenau, Hendrik‐Tobias

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  20. 20
    Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors

    Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors 由 Perry, Nick, Moss, Sue, Dixon, Steve, Milner, Sue, Mokbel, Kefah, Lemech, Charlotte, Arkenau, Hendrik-Tobias, Duffy, Stephen, Pinker, Katja

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: